CRISPR European patent cancellation highlights procedural IP pitfalls

The European Patent Office’s revocation of a key patent relating to the revolutionary CRISPR technology sent shockwaves around the IP world last week. While the much-discussed ongoing US CRISPR dispute has raised fundamental questions about…